Topical retinoids have become a cornerstone of acne treatment. Among the newer topical agents, trifarotene 0.005% cream (Aklief; Galderma), a fourth-generation RAR-γ selective retinoid, has emerged as a promising therapeutic option with demonstrated efficacy across multiple end points, including scarring and pigmentary changes.
Source: Dermatology Times